Saltar al contenido

NAH: First Commercial Precision Dosing Model for Heparin

Today, InsightRX and Northern Arizona Healthcare (NAH) announced they will make InsightRX’s precision dosing software for heparin therapy available to NAH’s pharmacists at Flagstaff Medical Center. NAH expects this deployment to decrease the time it takes to therapeutically dose hospitalized patients with unfractionated heparin to treat and prevent blood clots, improving patient outcomes.

NAH is a multi-site, not-for-profit health system that views precision dosing as a transformative approach for advancing medical practice and recognizes InsightRX’s continuous learning platform as the solution for clinicians to standardize high-quality care practices.

avatar del autor
LabNews Media LLC
Los Editores Jefe de labnews.ai son Marita Vollborn y Vlad Georgescu. Son autores de bestsellers, redactores científicos y periodistas científicos desde 1994.Más detalles sobre su trabajo en X-Press Journalistenbüro (https://xpress-journalisten.com).Más información en Wikipedia:Sobre Marita: https://de.wikipedia.org/wiki/Marita_Vollborn Sobre Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
LabNews Media LLC

LabNews Media LLC

Los Editores Jefe de labnews.ai son Marita Vollborn y Vlad Georgescu. Son autores de bestsellers, redactores científicos y periodistas científicos desde 1994.Más detalles sobre su trabajo en X-Press Journalistenbüro (https://xpress-journalisten.com).Más información en Wikipedia:Sobre Marita: https://de.wikipedia.org/wiki/Marita_Vollborn Sobre Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu